Company page

Valbiotis Sa

Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €32.07 million. The company focuses on the development of innovative solutions for the prevention and management of metabolic diseases. Valbiotis is committed to advancing research and delivering products that address significant health challenges.